DelveInsight's "Congenital Adrenal Hyperplasia Pipeline Insight 2025" report provides comprehensive insights about 5+ companies and 8+ pipeline drugs in the Congenital Adrenal Hyperplasia pipeline ...

Patients with primary adrenal insufficiency had a higher risk for all-cause mortality than the general population or control individuals without the condition, with cardiovascular disease being a ...

People with classic congenital adrenal hyperplasia (CAH) may suffer from impaired bone health, largely due to standard treatments. Most often caused by a genetic mutation in the 21-hydroxylase enzyme, ...

In another shocking incident, a second newborn girl, bitten by rats at Madhya Pradesh government-run Maharaja Yashwantrao Hospital (MYH) in Indore, died on Wednesday. The hospital administration ...

In people with CAH, a genetic condition leads to a lack of one of the enzymes (a step in the building process) needed to produce one or more of the above hormones. There are two major types of CAH: ...

SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) for ...

Science has a way of nudging us out of our certainties. What once seemed fixed can, with the next experiment or field study, turn out to be more complicated. Few areas have shifted more dramatically ...

Congenital adrenal hyperplasia (CAH) is a group of inherited conditions in which the adrenal glands cannot make certain hormones, most commonly due to a deficiency of the enzyme 21-hydroxylase. This ...

The treatments for both classic and nonclassic congenital adrenal hyperplasia (CAH) include medication, surgery, and psychological support, or a combination of all three. Some people who have CAH, ...

Management of classic congenital adrenal hyperplasia (CAH), a rare genetic condition diagnosed at birth, requires a careful balance between androgen and cortisol. Most often caused by a genetic ...